Colorectal Cancer Metastatic — Panitumumab Skin Toxicity Prevention Trial
Citation(s)
Double-blind, Phase II Study to Assess the Effectiveness of Lycopene vs Placebo to Reduce Skin Toxicity in Patients With Colorectal Carcinoma Treated With Panitumumab